Healthcare >> CEO Interviews >> April 9, 2015
Bill Kachioff is Biocept, Inc.’s Senior Vice President of Finance and Chief Financial Officer of Biocept, Inc. He is experienced in corporate finance, investor relations, corporate governance and manufacturing accounting and systems. He has over 20 years of life science industry experience, having most recently served as CFO at Althea Technologies, a pharmaceutical contract manufacturing organization. He was also a CFO Partner with Tatum LLC, a national executive services firm focused on the office of the CFO, where he served a variety of life science industry clients in senior financial management roles. Prior to joining Tatum LLC, Mr. Kachioff was CFO at MicroIslet, a publicly traded biotech company developing cell transplant therapies for insulin dependent diabetes. He was Director of Finance at Cutera, where he helped prepare the company for the commercial launch of its first product and its initial public offering. He has also served in a variety of financial management roles at Coulter Pharmaceutical, Vivus and Abbott Labs. Mr. Kachioff has a B.S. in management from the State University of New York at Buffalo and is a member of the American Institute of Certified Public Accountants and the Association of Bioscience Financial Officers. He began his professional career as an Auditor with Deloitte & Touche LLP. Profile
Mr. Nall: To address your second question first,
